3D Whole Breast Ultrasound Screenings

Total Page：16

File Type：pdf, Size：1020Kb

THE DIFFERENCE 3D WHOLE BREAST ULTRASOUND SCREENINGS SimonMed uses the new 3D Volumetric Breast Ultrasound technology. When combined with mammography this helps our radiologists provide more accurate and reliable diagnoses and a better chance to diagnose breast cancer early at a more treatable stage. This is the ideal imaging choice for women with dense breast tissue. ADVANTAGES 40% of women age 40 No radiation and over have dense breast.1 15-30 min quick, painless, Cancer is 4-6 times more likely in women and comfortable exam with extremely dense breasts than in women with fatty breasts. Reproducible and reliable automated 3D whole breast Mammograms can miss more than 50% imaging designed for accuracy of cancers in women with dense breast. and follow-up Comprehensive full-field 3D Breast Ultrasound found 7.1 more cancers volumetric imaging and unique than 2D Mammograms and 3.1 more cancers anatomical coronal view. than 3D Mammograms.2 1Breast density information [Internet]. American College of Radiology [Cited 2016 June]. Available from:http://densebreast-info.org/TechnologyMammography.aspx 2http://ascopubs.org/doi/abs/10.1200/JCO.2015.63.4147 1.866.614.8555 SIMONMED.COM THE DIFFERENCE 3D ULTRASOUND CASE STUDY Normal Mammogram Positive 3D Whole Breast Ultrasound 61-year-old female Positive 3D Oblique View Positive 3D Frontal View Heterogeneously dense breast LEFT BREAST CANCER FOUND ONLY ON 3D WHOLE BREAST ULTRASOUND ALL BREASTS ARE NOT THE SAME ROUTINE SCREENING ANNUAL ROUTINE Breast Density is determined through a woman’s MAMMOGRAM FOLLOW-UP mammogram and is classified in one of four categories: A,B,C, and D. Breasts that are within Normal the category C (heterogeneously dense) or category > 50% Dense No D (extremely dense) are considered dense. Yes SUPPLEMENTAL 3D WHOLE BREAST US Normal SCREENING Abnormal Diagnostic Normal Imaging Abnormal Biopsy Normal SimonMed utilizes PowerLook, an automated 3D WHOLE BREAST US SCREENING Malignant breast density assessment tool for accurate and Improved Breast Center Detection objective breast density scoring. This standardizes breast density assessment between radiologists by delivering automatic and consistent breast density results across patient populations. 1.866.614.8555 SIMONMED.COM.

Copy Link

Recommended publications

Future of Breast Elastography
Future of breast elastography Richard Gary Barr1,2 1Department of Radiology, Northeastern Ohio Medical University, Rootstown, OH; 2Southwoods Imaging, Youngstown, OH, USA REVIEW ARTICLE Both strain elastography and shear wave elastography have been shown to have high sensitivity https://doi.org/10.14366/usg.18053 pISSN: 2288-5919 • eISSN: 2288-5943 and specificity for characterizing breast lesions as benign or malignant. Training is important for Ultrasonography 2019;38:93-105 both strain and shear wave elastography. The unique feature of benign lesions measuring smaller on elastography than B-mode imaging and malignant lesions appearing larger on elastography is an important feature for characterization of breast masses. There are several artifacts which can contain diagnostic information or alert to technique problems. Both strain and shear wave elastography continue to have improvements and new techniques will soon be available for Received: September 21, 2018 clinical use that may provide additional diagnostic information. This paper reviews the present Revised: January 4, 2019 Accepted: January 4, 2019 state of breast elastography and discusses future techniques that are not yet in clinical practice. Correspondence to: Richard Gary Barr, MD, PhD, Keywords: Breast; Elasticity imaging techniques; Strain; Shear wave; Strain ratio; Southwoods Imaging, 7623 Market Street, Youngstown, OH 44512, USA Breast neoplasms Tel. +1-330-965-5100 Fax. +1-330-965-5109 E-mail: [email protected] Introduction The use of palpation to determine the stiffness of a lesion has been used since the time of the ancient Greeks and Egyptians [1]. Stiff, non-mobile lesions of the breast have a high probability of being malignant.
[Show full text]
Understanding Cost & Coverage Issues with Diagnostic Breast Imaging
Understanding Cost & Coverage Issues with Diagnostic Breast Imaging JANUARY 2019 The following report represents key findings from The Martec Group’s primary and secondary research efforts. The team was instructed to explore the cost and coverage issue with breast diagnostic imaging in order to equip Susan G. Komen with the information necessary to strategize efforts at the state and federal levels. TABLE OF CONTENTS: I. A Brief Summary of Findings ................................................................................................................... 3 II. Project Background ..................................................................................................................................... 3 III. Study Objectives ........................................................................................................................................... 3 IV. Research Methodology .............................................................................................................................. 3 V. Patient Perspective ...................................................................................................................................... 4 VI. Health/Insurance Professional Perspective ...................................................................................... 5 VII. Cost Analysis .................................................................................................................................................. 6 VIII. Study Conclusions .......................................................................................................................................
[Show full text]
3D Ultrasound Elastography for Early Detection of Lesions. Evaluation on a Pressure Ulcer Mimicking Phantom
3D Ultrasound Elastography for Early Detection of Lesions. Evaluation on a Pressure Ulcer Mimicking Phantom. Jean-François Deprez, Guy Cloutier, Cedric Schmitt, Claudine Gehin, André Dittmar, Olivier Basset, Elisabeth Brusseau To cite this version: Jean-François Deprez, Guy Cloutier, Cedric Schmitt, Claudine Gehin, André Dittmar, et al.. 3D Ultrasound Elastography for Early Detection of Lesions. Evaluation on a Pressure Ulcer Mim- icking Phantom.. Conference proceedings : .. Annual International Conference of the IEEE En- gineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual Conference, Institute of Electrical and Electronics Engineers (IEEE), 2007, 1, pp.79-82. 10.1109/IEMBS.2007.4352227. inserm-00192829 HAL Id: inserm-00192829 https://www.hal.inserm.fr/inserm-00192829 Submitted on 29 Nov 2007 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. HAL author manuscript Conf Proc IEEE Eng Med Biol Soc 2007;1:79-82 3D Ultrasound Elastography for Early Detection of Lesions. Evaluation on a Pressure Ulcer Mimicking Phantom. Jean-François Deprez, Guy Cloutier, Cédric Schmitt, HAL author manuscript inserm-00192829, version 1 Claudine Gehin, André Dittmar, Olivier Basset and Elisabeth Brusseau Abstract— A pressure ulcer is a damaged tissue area induced of bedsores affect these two locations.
[Show full text]
Benefits and Risk of Fetal 3D Ultrasound
Benefits and Risk of Fetal 3D Ultrasound ABSTRACT The purpose of this literature review was to survey available information and research related to routine three- dimensional (3D) ultrasound technology in obstetrics, with an emphasis on current medical uses, safety, and availability issues. Several data bases, including Cochrane, WHO, NIH, CINALH, Blackwell Synergy, ERIC, PubMed, and Medline, were used along with information from Internet search engines. Although fetal 3D ultra- sound is used in both medical and commercial settings, recent studies focus on its possible uses rather than the more difficult issues of safety and commercial applications. Professional organizations associated with ul- trasound technology support limiting ultrasounds in pregnancy to medically necessary events, whereas com- mercial venues use “direct to consumer” marketing to promote this technology as a way to “see” the baby be- fore it is born. How safe is routine or frequent use of 3D ultrasound? Further research is needed to address these important questions. Key Words: Fetal ultrasonography; Ultrasonography, fetal; Ultrasonography, prenatal. 102 VOLUME 32 | NUMBER 2 March/April 2007 ince the early 2000s, opportunities for captur- images of the body, it replaces the need for ionizing (x- ing the lifelike image of a developing fetus have ray) methods to obtain the same information. Fetal scan- emerged in shopping malls around the world ning with two-dimensional (2D) ultrasounds, which de- (Gordon, 2003). Parents can now purchase pict length and width, has been used routinely in obstet- Sthree-dimensional (3D) ultrasound images by rics since the 1960s, but these images are black and white, merely entering a mall and leaving with pic- flat and grainy, and need an expert to interpret the results.
[Show full text]
Breast Ultrasound Accreditation Program Requirements
Breast Ultrasound Accreditation Program Requirements OVERVIEW ........................................................................................................................................................................... 1 MANDATORY ACCREDITATION TIME REQUIREMENTS .......................................................................................................... 2 PERSONNEL QUALIFICATIONS ..................................................................................................................................... 2 INTERPRETING PHYSICIAN .................................................................................................................................................... 2 SONOGRAPHER/TECHNOLOGIST ........................................................................................................................................... 5 EQUIPMENT ......................................................................................................................................................................... 5 QUALITY CONTROL .......................................................................................................................................................... 6 ACCEPTANCE TESTING ......................................................................................................................................................... 6 ANNUAL SURVEY ................................................................................................................................................................
[Show full text]
Evaluation of Nipple Discharge
New 2016 American College of Radiology ACR Appropriateness Criteria® Evaluation of Nipple Discharge Variant 1: Physiologic nipple discharge. Female of any age. Initial imaging examination. Radiologic Procedure Rating Comments RRL* Mammography diagnostic 1 See references [2,4-7]. ☢☢ Digital breast tomosynthesis diagnostic 1 See references [2,4-7]. ☢☢ US breast 1 See references [2,4-7]. O MRI breast without and with IV contrast 1 See references [2,4-7]. O MRI breast without IV contrast 1 See references [2,4-7]. O FDG-PEM 1 See references [2,4-7]. ☢☢☢☢ Sestamibi MBI 1 See references [2,4-7]. ☢☢☢ Ductography 1 See references [2,4-7]. ☢☢ Image-guided core biopsy breast 1 See references [2,4-7]. Varies Image-guided fine needle aspiration breast 1 Varies *Relative Rating Scale: 1,2,3 Usually not appropriate; 4,5,6 May be appropriate; 7,8,9 Usually appropriate Radiation Level Variant 2: Pathologic nipple discharge. Male or female 40 years of age or older. Initial imaging examination. Radiologic Procedure Rating Comments RRL* See references [3,6,8,10,13,14,16,25- Mammography diagnostic 9 29,32,34,42-44,71-73]. ☢☢ See references [3,6,8,10,13,14,16,25- Digital breast tomosynthesis diagnostic 9 29,32,34,42-44,71-73]. ☢☢ US is usually complementary to mammography. It can be an alternative to mammography if the patient had a recent US breast 9 mammogram or is pregnant. See O references [3,5,10,12,13,16,25,30,31,45- 49]. MRI breast without and with IV contrast 1 See references [3,8,23,24,35,46,51-55].
[Show full text]
Screening Automated Whole Breast Ultrasound
Screening Automated Whole Breast Ultrasound Screening Automated Whole Breast Ultrasound Stanford now offers screening automated whole breast ultrasound (SAWBU) at our Stanford Medicine Cancer Center Palo Alto location. This is an optional test that can be used as a supplement to screening mammography in women with mammographically dense breasts. It can find cancers that cannot be seen on mammograms due to overlap with dense breast tissue. Stanford uses automated whole breast technique, a new method developed for accuracy and efficiency. Who is a candidate for SAWBU What will happen during the How is SAWBU exam is examination? SAWBU examination? different? This is an optional test to supplement You will lie on your back, and gel will Screening automated screening mammography in women be applied to your breast. whole breast ultrasound who: uses sound waves (no radi- A large ultrasound handpiece will be • Undergo routine screening with ation) to create 3D pictures placed on the breast, and the system mammography. of the breast tissue, using will automatically take a “sweep” • Have no current signs or a new automated method that obtains ultrasound images of symptoms of breast cancer. developed for accuracy and the tissue from top to bottom. The • Have mammographically dense efficiency. handpiece will be repositioned to take (heterogeneously or extremely other “sweeps” to include all of the It can find cancers that dense) breasts. breast tissue. cannot be seen on mam- • Are not at “high risk" undergoing mograms alone due to supplemental screening with An exam of both breasts takes less overlap with dense breast breast MRI. Screening ultra- than 20 minutes to obtain.
[Show full text]
Evaluation of the Quantitative Accuracy of a Commercially-Available Positron Emission Mammography Scanner
The Texas Medical Center Library DigitalCommons@TMC The University of Texas MD Anderson Cancer Center UTHealth Graduate School of The University of Texas MD Anderson Cancer Biomedical Sciences Dissertations and Theses Center UTHealth Graduate School of (Open Access) Biomedical Sciences 8-2010 EVALUATION OF THE QUANTITATIVE ACCURACY OF A COMMERCIALLY-AVAILABLE POSITRON EMISSION MAMMOGRAPHY SCANNER Adam Springer Follow this and additional works at: https://digitalcommons.library.tmc.edu/utgsbs_dissertations Part of the Diagnosis Commons, Equipment and Supplies Commons, and the Other Medical Sciences Commons Recommended Citation Springer, Adam, "EVALUATION OF THE QUANTITATIVE ACCURACY OF A COMMERCIALLY-AVAILABLE POSITRON EMISSION MAMMOGRAPHY SCANNER" (2010). The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences Dissertations and Theses (Open Access). 64. https://digitalcommons.library.tmc.edu/utgsbs_dissertations/64 This Thesis (MS) is brought to you for free and open access by the The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences at DigitalCommons@TMC. It has been accepted for inclusion in The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences Dissertations and Theses (Open Access) by an authorized administrator of DigitalCommons@TMC. For more information, please contact [email protected]. EVALUATION OF THE QUANTITATIVE ACCURACY OF A COMMERCIALLY- AVAILABLE POSITRON EMISSION MAMMOGRAPHY SCANNER
[Show full text]
Three-Dimensional Shear Wave Elastography on Conventional Ultrasound Scanners with External Vibration
Physics in Medicine & Biology PAPER Three-dimensional shear wave elastography on conventional ultrasound scanners with external vibration To cite this article: Chengwu Huang et al 2020 Phys. Med. Biol. 65 215009 View the article online for updates and enhancements. This content was downloaded from IP address 130.126.255.71 on 25/11/2020 at 16:30 Phys. Med. Biol. 65 (2020) 215009 https://doi.org/10.1088/1361-6560/aba5ea Physics in Medicine & Biology PAPER Three-dimensional shear wave elastography on conventional RECEIVED 3 March 2020 ultrasound scanners with external vibration REVISED 2 July 2020 Chengwu Huang1, Pengfei Song1,3,4, Daniel C Mellema1, Ping Gong1, U-Wai Lok1, Shanshan Tang1, ACCEPTED FOR PUBLICATION 1,5 1 1 2 2 14 July 2020 Wenwu Ling , Duane D Meixner , Matthew W Urban , Armando Manduca , James F Greenleaf and 1 PUBLISHED Shigao Chen 2 November 2020 1 Department of Radiology, Mayo Clinic College of Medicine and Science, Rochester, MN 55905, United States of America 2 Department of Physiology and Biomedical Engineering, Mayo Clinic College of Medicine and Science, Rochester, MN 55905, United States of America 3 Department of Electrical and Computer Engineering, University of Illinois at Urbana-Champaign, Urbana, IL 61801, United States of America 4 Beckman Institute for Advanced Science and Technology, University of Illinois at Urbana-Champaign, Urbana, IL 61801, United States of America 5 Department of Ultrasound, West China Hospital of Sichuan University, Chengdu, Sichuan 610041, People’s Republic of China E-mail: [email protected] Keywords: ultrasound, shear wave elastography, three-dimensional imaging, liver fibrosis Supplementary material for this article is available online Abstract Two-dimensional (2D) ultrasound shear wave elastography (SWE) has been widely used for soft tissue properties assessment.
[Show full text]
Meeting Name
Josh Morse, Director March 20, 2015 WA –Health Technology Assessment Program Overview Josh Morse, Director Health Technology Assessment Program March 20, 2015 WA ‐ Health Technology Assessment Program Updates Today: • Testosterone Testing May 15, 2015: • Bariatric Surgery • Imaging for Rhinosinusitus WA ‐ Health Technology Clinical Committee 1 Josh Morse, Director March 20, 2015 WA –Health Technology Assessment WA ‐ Health Technology Assessment Background . The Health Technology Assessment Program (HTA) is located within the Health Care Authority (HCA) . 2006 legislation designed HTA program to use evidence reports and a panel of clinicians to make coverage decisions for certain medical procedures and tests based on evidence of: • Safety • Efficacy/ Effectiveness • Cost‐Effectiveness WA ‐ Health Technology Assessment Background . Multiple state agency programs participate to identify topics and implement policy decisions: • Health Care Authority – Uniform Medical Plan – Medicaid • Labor and Industries • Corrections . Implementation: Agencies implement determinations of the HTA program within their existing statutory framework. 4 WA ‐ Health Technology Clinical Committee 2 Josh Morse, Director March 20, 2015 WA –Health Technology Assessment WA ‐ Health Technology Assessment Purpose: Pay for What Works Ensure medical treatments, devices and services paid for with state health care dollars are safe and proven to work. Provide resources for state agencies purchasing health care . Develop scientific, evidence‐based reports on medical devices,
[Show full text]
Commercial Reimbursement and Utilization for Invenia ABUS (Automated Breast Ultrasound)
Commercial Reimbursement and Utilization for Invenia ABUS (Automated Breast Ultrasound) Background interpreting physician, referring physician/Health Care Provider (HCP), and patient.6 Specifically, the MQSA encourages education More than one-half of women younger than 50 years old and and outreach to patients from medical/scientific organizations, approximately one-third of women 50 years and older have industry, and interpreting physicians. In addition, outreach to dense breasts in the US.1 Higher breast density is associated referring physicians is encouraged from professional organizations with decreased mammographic sensitivity and specificity and and Continuing Medical Education (CME) providers.6 increased breast cancer risk.2 Due to the shortcomings of mammography in this population of women, an individualized Despite widely available options for additional screening and multimodal screening approach is recommended to improve the legislation mandating density inform, uptake and adoption of early detection of breast cancer. No clinical guidelines explicitly supplemental screening has lagged. In addition to knowledge recommend use of supplemental breast cancer screening on gaps, one study identified reimbursement uncertainties (e.g. women with dense breasts,3 but as of March 2018, 33 states have billing, coding and coverage) as a key factor for slow uptake. In enacted legislation requiring that breast density, in addition to 2015, the CPT® codebook was updated to include two new codes mammography results, be reported to women undergoing such for breast ultrasound, CPT 76641 and 76642, for complete and procedures; additional states have introduced or are currently limited exams, respectively.7 These codes replaced CPT 76645. working on legislation.4 Most states require specific density The new and old codes alike do not differentiate the technology inform language distinguishing dense (i.e., BI-RADS® C and D) used to perform an exam (handheld vs.
[Show full text]
Breast Imaging Faqs
Breast Imaging Frequently Asked Questions Update 2021 The following Q&As address Medicare guidelines on the reporting of breast imaging procedures. Private payer guidelines may vary from Medicare guidelines and from payer to payer; therefore, please be sure to check with your private payers on their specific breast imaging guidelines. Q: What differentiates a diagnostic from a screening mammography procedure? Medicare’s definitions of screening and diagnostic mammography, as noted in the Centers for Medicare and Medicaid’s (CMS’) National Coverage Determination database, and the American College of Radiology’s (ACR’s) definitions, as stated in the ACR Practice Parameter of Screening and Diagnostic Mammography, are provided as a means of differentiating diagnostic from screening mammography procedures. Although Medicare’s definitions are consistent with those from the ACR, the ACR's definitions of screening and diagnostic mammography offer additional insight into what may be included in these procedures. Please go to the CMS and ACR Web site links noted below for more in- depth information about these studies. Medicare Definitions (per the CMS National Coverage Determination for Mammograms 220.4) “A diagnostic mammogram is a radiologic procedure furnished to a man or woman with signs and symptoms of breast disease, or a personal history of breast cancer, or a personal history of biopsy - proven benign breast disease, and includes a physician's interpretation of the results of the procedure.” “A screening mammogram is a radiologic procedure furnished to a woman without signs or symptoms of breast disease, for the purpose of early detection of breast cancer, and includes a physician’s interpretation of the results of the procedure.
[Show full text]